Table 1.
Subject demographics for lung tissue samples
| Patient ID | Description | Sex | Age | Pack years | Smoking status | Lm mean ± SD (μm) | Lm range (μm) |
|---|---|---|---|---|---|---|---|
| 6965 | COPD | M | 62 | 50 | Former | 716 ± 164 | 494-982 |
| 6967 | COPD | F | 61 | 25 | Former | 414 ± 82 | 334-585 |
| 6968 | COPD | F | 63 | 38 | Former | 724 ± 252 | 357-1,013 |
| 6969 | COPDa,b | F | 56 | 54 | Former | 1,822 ± 1270 | 521-4,620 |
| 6970 | COPDc | M | 55 | 15 | Former | 1,352 ± 599 | 647-2,551 |
| 6971 | COPD | M | 59 | 30 | Former | 1,097 ± 441 | 720-2,101 |
| 6982 | Donor | M | 59 | - | Never | 384 ± 47 | 344-473 |
| 6983 | Donor | M | 62 | 24 | Former | 289 ± 41 | 231-352 |
Subjects with COPD had FEV1/FVC <70% and FEV1 <25% predicted. a-cSome patients had other diseases: avon Willebrand disease; bhypertension; cα1-antitrypsin deficiency disease.